XML 71 R60.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHAREHOLDERS EQUITY (Details Narrative) - USD ($)
6 Months Ended
Feb. 11, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Sep. 30, 2021
Common Stock Share Sold         2,869,442
Issued Warrants In Concurrent Private Placement         1,434,721
Issued Warrants In Concurrent Placement Agent         172,167
Issued Shares Of Common Stock During Period   51,570 50,000    
Issued Shares Of Common Stock During Period, Value   $ 54,000 $ 228,000    
Issued Shares Of Common Stock During Period, Shares   51,750      
Proceeds From Issuance Of Warrants   $ 4,581,651      
Exercise Price Of Warrant         $ 1.68
Warrant Amendment, Description In connection with the Warrant Amendment, TOMI repurchased the warrant from Dr. Shane (the “Repurchase”) for an aggregate cash consideration of $314,500, representing a 15% discount of the net exercise cash value of the Warrant, which was calculated using the closing price of the Common Stock on the Nasdaq on February 11, 2021 of $5.36, less the exercise price of the warrants in the amount of $2.40. On the same date        
Aggregate Cash Consideration   $ 314,500      
Warrants Issued Upon Purchase Share Of Common Stock 125,000        
Exercise Price         $ 2.18
COO [Member] | January 2022 [Member] | Equity Option [Member]          
Warrants Issued Upon Purchase Share Of Common Stock   172,500      
Exercise Price   $ 1.12      
Grant Fair Value Of Per Share   $ 1.68      
Stock Options Term   10 years      
Volatility Rate   156.00%      
Expected Dividend Yield   0.00%      
Risk Free Interest Rate   1.65%      
Expected Life Term   5 years      
Fair Value Of Stock Warrant   $ 178,281      
CFO [Member] | January 2022 [Member] | Equity Option [Member]          
Warrants Issued Upon Purchase Share Of Common Stock   40,000      
Exercise Price   $ 1.12      
Grant Fair Value Of Per Share   $ 1.03      
Stock Options Term   10 years      
Volatility Rate   156.00%      
Expected Dividend Yield   0.00%      
Risk Free Interest Rate   1.65%      
Expected Life Term   5 years      
Fair Value Of Stock Warrant   $ 41,340      
Cumulative Convertible Series A Preferred Stock [Member]          
Preferred Stock Shares   1,000,000   1,000,000  
Cumulative Convertible Preferred Stock; Shares Issued   63,750   63,750  
Cumulative Convertible Preferred Stock; Shares Outstanding   63,750   63,750  
Cumulative Convertible Preferred Stock; Par Value   $ 0.01   $ 0.01  
Cumulative Convertible Series B Preferred Stock [Member]          
Issued Shares Of Common Stock Stated Value   $ 1,000      
Preferred Stock Shares   4,000   4,000  
Cumulative Convertible Preferred Stock; Shares Issued   0   0  
Cumulative Convertible Preferred Stock; Shares Outstanding   0   0  
Cumulative Convertible Preferred Stock; Par Value   $ 1,000   $ 1,000  
Stock Options | COO [Member]          
Exercise Price   1.12      
Grant Fair Value Of Per Share   $ 2.18      
Stock Options Term   10 years      
Volatility Rate   156.00%      
Expected Dividend Yield   0.00%      
Risk Free Interest Rate   1.65%      
Aggregate Shares Purchase Of Stock Option   57,500      
Fair Value Of Stock Option   $ 59,427      
Expected Life Term   5 years